Abeona Therapeutics Inc. (0H7R.L)
USD 5.88
(-2.0%)
USD 5.88
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.5 Million | 1.41 Million | 3 Million | 10 Million | - | 2.99 Million |
| Cost of Revenue | 3.19 Million | 4.57 Million | 4.46 Million | 30.13 Million | 8.67 Million | 38.69 Million |
| Gross Profit | 302 Thousand | -3.16 Million | -1.46 Million | -20.13 Million | -8.67 Million | -35.7 Million |
| Operating Expenses | 48.5 Million | 42.09 Million | 55.9 Million | 52.9 Million | 68.41 Million | 58.8 Million |
| Selling, General and Administrative Expenses | 19 Million | 13.12 Million | 21.58 Million | 22.76 Million | 19.84 Million | 20.1 Million |
| Research and Development Expenses | 31.09 Million | 28.96 Million | 34.32 Million | 30.13 Million | 48.56 Million | 38.69 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 51.7 Million | 46.67 Million | 60.37 Million | 58.5 Million | 77.09 Million | 61.16 Million |
| Operating Income | -48.2 Million | -45.25 Million | -57.37 Million | -48.5 Million | -77.09 Million | -58.16 Million |
| Interest Expense | 418 Thousand | 736 Thousand | 3.67 Million | 4.11 Million | - | - |
| Income Tax Expense | - | 3.78 Million | - | - | - | 2.19 Million |
| Earnings before Tax | -54.18 Million | -39.69 Million | -84.93 Million | -84.23 Million | -76.28 Million | -56.67 Million |
| Net Income | -54.18 Million | -39.69 Million | -84.93 Million | -84.23 Million | -76.28 Million | -56.67 Million |
| Earnings Per Share Basic | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 | -29.81 |
| Earnings Per Share Diluted | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 | -29.81 |
| Weighted Average Shares Outstanding | 21.38 Million | 7.86 Million | 3.93 Million | 3.7 Million | 2.01 Million | 1.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.38 Million | 7.86 Million | 3.93 Million | 3.7 Million | 2.01 Million | 1.9 Million |
| Gross Margin | 0.09 | -2.24 | -0.49 | -2.01 | - | -11.91 |
| EBIT Margin | -14.45 | -28.77 | -17.64 | -4.29 | - | -18.61 |
| Profit Margin | -15.48 | -28.07 | -28.31 | -8.42 | - | -18.90 |
| EBITDA | -50.57 Million | -34.38 Million | -76.8 Million | -74.51 Million | -67.6 Million | -55.8 Million |
| Earnings Before Tax Margin | -13.77 | -32.01 | -19.12 | -4.85 | - | -19.40 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 3.5 Million | - | 3.5 Million |
| Cost of Revenue | 1.66 Million | 724 Thousand | 721 Thousand | 3.19 Million | 751 Thousand | 838 Thousand |
| Gross Profit | -1.66 Million | -724 Thousand | -721 Thousand | 302 Thousand | -751 Thousand | 2.66 Million |
| Operating Expenses | 16.19 Million | 13.6 Million | 12.48 Million | 48.5 Million | 10.58 Million | 14.28 Million |
| Selling, General and Administrative Expenses | 6.97 Million | 6.39 Million | 5.1 Million | - | 3.43 Million | 5.75 Million |
| Research and Development Expenses | 9.21 Million | 7.2 Million | 7.37 Million | - | 7.14 Million | 8.52 Million |
| Other Expenses | - | 724 Thousand | - | - | - | - |
| Cost and Expenses | 17.86 Million | 14.33 Million | 13.2 Million | 51.7 Million | 11.33 Million | 15.11 Million |
| Operating Income | -17.86 Million | -14.33 Million | -13.2 Million | -48.2 Million | -11.33 Million | -11.61 Million |
| Interest Expense | 1.07 Million | 952 Thousand | 109 Thousand | 418 Thousand | 105 Thousand | 103 Thousand |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | 7.4 Million | -31.57 Million | -16.59 Million | -54.18 Million | -11.83 Million | -16.65 Million |
| Net Income | 7.4 Million | -31.57 Million | -16.59 Million | -54.18 Million | -11.83 Million | -16.65 Million |
| Earnings Per Share Basic | 0.19 | -1.16 | -0.65 | - | -0.48 | -0.92 |
| Earnings Per Share Diluted | -0.26 | -1.16 | -0.65 | - | -0.48 | -0.92 |
| Weighted Average Shares Outstanding | 40.01 Million | 27.31 Million | 25.55 Million | 21.38 Million | 24.79 Million | 18.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.22 Million | 27.31 Million | 25.55 Million | 21.38 Million | 24.79 Million | 18.01 Million |
| Gross Margin | - | - | - | 0.09 | - | 0.76 |
| EBIT Margin | - | - | - | - | - | -3.08 |
| Profit Margin | - | - | - | -15.48 | - | -4.76 |
| EBITDA | -16.19 Million | -13.6 Million | -12.48 Million | - | -10.58 Million | -10.78 Million |
| Earnings Before Tax Margin | - | - | - | -13.77 | - | -3.32 |
SIYSIL
MEDANTA
BIR
TEXRAIL
OGEN
PSHZF